{"transactions":[{"id":924402,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68154,"kind":"person","name":"LaCascia Michael","position":1,"cik":"0001831755","reported_name":"LaCascia Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-02-02T21:03:48.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":295000,"price":5.71,"value":1684450.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares of common stock on January 30, 2027, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter."}],"balance_after":295000,"derivative":{"exercise_price":5.71,"expiration_date":"2036-01-29","underlying":"Common Stock","underlying_shares":295000},"source":{"system":"sec-edgar","filing":"0001831755-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000183175526000002/primarydocument.xml","form_type":"4"}},{"id":1295288,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68154,"kind":"person","name":"LaCascia Michael","position":1,"cik":"0001831755","reported_name":"LaCascia Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-24T21:06:45.000Z","date":"2025-01-22","kind":"grant","planned":false,"acquired":true,"shares":126000,"price":4.37,"value":550620.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares of common stock on January 22, 2026, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter."}],"balance_after":126000,"derivative":{"exercise_price":4.37,"expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":126000},"source":{"system":"sec-edgar","filing":"0001562180-25-000499","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218025000499/primarydocument.xml","form_type":"4"}},{"id":1670621,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68154,"kind":"person","name":"LaCascia Michael","position":1,"cik":"0001831755","reported_name":"LaCascia Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-25T21:01:40.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":3.06,"value":306000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares of common stock on January 24, 2025, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter."}],"balance_after":100000,"derivative":{"exercise_price":3.06,"expiration_date":"2034-01-23","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001562180-24-000605","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218024000605/primarydocument.xml","form_type":"4"}},{"id":2041763,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68154,"kind":"person","name":"LaCascia Michael","position":1,"cik":"0001831755","reported_name":"LaCascia Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-30T22:03:03.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares of common stock on January 26, 2024, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter."}],"balance_after":90000,"derivative":{"exercise_price":8.38,"expiration_date":"2033-01-25","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001562180-23-000724","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218023000724/primarydocument.xml","form_type":"4"}},{"id":2422110,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68154,"kind":"person","name":"LaCascia Michael","position":1,"cik":"0001831755","reported_name":"LaCascia Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-28T21:26:55.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested as to 25% of the underlying shares of common stock on January 26, 2023, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested."}],"balance_after":135000,"derivative":{"exercise_price":14.87,"expiration_date":"2032-01-25","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001562180-22-000749","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218022000749/primarydocument.xml","form_type":"4"}},{"id":2974198,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68154,"kind":"person","name":"LaCascia Michael","position":1,"cik":"0001831755","reported_name":"LaCascia Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-19T01:18:32.000Z","date":"2020-11-17","kind":"grant","acquired":true,"shares":162162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the stock option shall vest on November 9, 2021, with the remainder vesting in 12 substantially equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer through such applicable vesting dates."}],"balance_after":162162,"derivative":{"exercise_price":17,"expiration_date":"2030-11-16","underlying":"Common Stock","underlying_shares":162162},"source":{"system":"sec-edgar","filing":"0000899243-20-031581","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000089924320031581/doc4.xml","form_type":"4"}}]}